Register entry

Anjan Drug Private Limited

Data as of · How to read this entry

Registered sites
2
Active NDC listings
3
Live patents
0
Countries
1
Base
India
Authorisation

Registered operations

Active ingredient (API) manufacture2
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Anjan Drug Private LimitedPlot No. 109, 110, 115 & 116, SIDCO Pharmaceutical Industrial Estate, Thirupporur Taluk, Chengalpattu District, Alathur, Tamil Nadu 603110, India (IND)Active ingredient (API) manufacture3005782924916410202
Anjan Drug Private LimitedPlot No.: 85-88 & 105-109 & 112-116, SIPCOT Export Promotion Industrial Park (EPIP), Gummidipoondi, District Tiruvallur, Tamil Nadu 601201, India (IND)Active ingredient (API) manufacture3009402416915842021
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 bulk ingredient. By marketing category: BULK INGREDIENT 3.

Dosage formNDCs
powder3
RouteNDCs
Labeller name on the listingNDCs
anjan drug private limited3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
-Divalproex Sodiumpowder23639-0001BULK INGREDIENT
-Gabapentinpowder23639-0002BULK INGREDIENT
-Valproic Acidpowder23639-0003BULK INGREDIENT
Compare

Comparable companies in India

Enquiry

Common questions

Is Anjan Drug Private Limited FDA approved?
Anjan Drug Private Limited holds 2 FDA-registered establishments in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Anjan Drug Private Limited's drugs manufactured?
The FDA register lists Alathur; District Tiruvallur. Registered operations: active ingredient (API) manufacture.
What drugs does Anjan Drug Private Limited make?
3 products are listed under Anjan Drug Private Limited in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.